CITYSCAPE: 1L tiragolumab + atezolizumab vs placebo + atezolizumab in PD-L1-selected NSCLC VJOncology 1:12 2 years ago 209 Далее Скачать
CITYSCAPE: Tiragolumab plus atezolizumab for non-small cell lung cancer ecancer 3:13 4 years ago 780 Далее Скачать
Phase 3 trials of atezolizumab versus standard chemotherapy in PD-L1-selected NSCLC EMJ 1:49 8 years ago 366 Далее Скачать
Dr Chitresh Aggarwal | Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a 1L CRSF - Cancer Research and Statistic Foundation 6:04 1 year ago 40 Далее Скачать
Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC AJMCtv 4:05 4 years ago 514 Далее Скачать
Dr Melissa Johnson: Tiragolumab Plus Atezolizumab Improves Objective Response in CITYSCAPE Trial AJMCtv 2:03 4 years ago 489 Далее Скачать
Final OS results of IMvigor130: 1L atezolizumab +/- chemotherapy in metastatic urothelial carcinoma VJOncology 2:18 1 year ago 172 Далее Скачать
What role does TIGIT inhibition have in treating hepatocellular carcinoma? VJOncology 3:52 1 year ago 201 Далее Скачать
ASCO Lung Cancer Roundtable - NSCLC - The CITYSCAPE Trial: Anti TIGIT & Immune Checkpoint Inhibitor GRACE - Global Resource for Advancing Cancer Education 8:35 4 years ago 647 Далее Скачать
Upcoming NSCLC trials in 2022: CheckMate 816 & KEYNOTE-091 VJOncology 2:01 2 years ago 796 Далее Скачать
HPN328, a tri-specific T-cell engager, in SCLC and neuroendocrine cancers VJOncology 0:42 2 years ago 270 Далее Скачать
IASLC Webinar: World Conference on Lung Cancer 2020 Highlights IASLC 59:17 3 years ago 1 703 Далее Скачать
T-Cell dynamics in response to neoadjuvant atezolizumab in early NSCLC VJOncology 2:03 2 years ago 170 Далее Скачать
IOU YouTube: How does TIGIT overpower cytotoxic T-cell activity? Dig Deeper Into Immuno-Oncology Research 1:06 2 years ago 805 Далее Скачать
Targeting TIGIT to Extend Immunotherapy Benefits to More Cancer Patients PeerView Oncology 55:16 2 years ago 947 Далее Скачать
TIGIT: harnessing the power of the immune system to help fight cancer Roche 3:45 2 years ago 36 357 Далее Скачать
Edward Garon, MD, examines dual immunotherapy approach in the CITYSCAPE trial OBRoncology 2:50 4 years ago 78 Далее Скачать